loading

Pds Biotechnology Corporation Borsa (PDSB) Ultime notizie

pulisher
09:00 AM

The growth track for PDS Biotechnology Corporation (PDSB) has changed recently - setenews.com

09:00 AM
pulisher
Nov 03, 2025

Tools to assess PDS Biotechnology Corporation’s risk profile2025 Dividend Review & Fast Gaining Stock Strategy Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will PDS Biotechnology Corporation stock go up soonEarnings Overview Summary & Free High Accuracy Swing Entry Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is PDS Biotechnology Corporation stock positioned for long term growthJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will PDS Biotechnology Corporation stock reach all time highs in 2025Earnings Growth Summary & Safe Entry Trade Signal Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why PDS Biotechnology Corporation stock is recommended by analystsJuly 2025 Movers & Precise Swing Trade Entry Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is PDS Biotechnology Corporation stock entering bullish territoryTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is PDS Biotechnology Corporation stock a good choice for value investorsJuly 2025 PreEarnings & Consistent Profit Trading Strategies - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Earnings visualization tools for PDS Biotechnology CorporationTrend Reversal & Reliable Trade Execution Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Multi factor analysis applied to PDS Biotechnology CorporationM&A Rumor & Real-Time Volume Trigger Notifications - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

What machine learning models say about PDS Biotechnology CorporationCPI Data & Fast Moving Trade Plans - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

PDS Biotechnology Stock Logs Best Session In 2 Months After FDA Fast-Track Push For Cancer Drug — Retail Bets On Early Approval - Stocktwits

Oct 31, 2025
pulisher
Oct 31, 2025

Building trade automation scripts for PDS Biotechnology CorporationTrade Exit Report & Safe Capital Growth Tips - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

PDS Biotechnology Seeks Accelerated FDA Pathway for Cancer Therapy - AD HOC NEWS

Oct 31, 2025
pulisher
Oct 31, 2025

What dividend safety score for PDS Biotechnology Corporation stockTrade Volume Summary & Fast Moving Market Watchlists - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

PDS Biotechnology Corporation’s volatility index tracking explainedRate Hike & Low Drawdown Investment Strategies - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

New Clinical and Translational Data on PDS Biotechnology’s Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

PDS Biotechnology Corporation Announces New Clinical and Translational Data on Pds0101 and Pds01adc to Be Presented At the 2025 Society for Immunotherapy of Cancer Annual Meeting - MarketScreener

Oct 30, 2025
pulisher
Oct 29, 2025

PDS Biotech stock soars after seeking expedited approval pathway for cancer drug - Investing.com India

Oct 29, 2025
pulisher
Oct 29, 2025

PDS Biotech to seek expedited approval pathway for PDS0101 in HPV16-positive head and neck cancer - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

PDS Biotechnology Corporation Seeks Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer Following Promising VERSATILE-002 Trial Results - Quiver Quantitative

Oct 29, 2025
pulisher
Oct 29, 2025

PDSB seeks FDA meeting to explore expedited path for PDS0101 - Stock Titan

Oct 29, 2025
pulisher
Oct 29, 2025

39.3-month mOS seen with PDS0101 as PDS Biotech (NASDAQ: PDSB) seeks FDA expedited path - Stock Titan

Oct 29, 2025
$37.84
price up icon 1.52%
$29.02
price up icon 1.11%
$103.05
price up icon 1.34%
$104.02
price up icon 0.06%
biotechnology ONC
$312.19
price up icon 0.10%
$185.72
price down icon 0.10%
Capitalizzazione:     |  Volume (24 ore):